BBNX

Beta Bionics, Inc. - Common Stock (BBNX)

About Beta Bionics, Inc. - Common Stock (BBNX)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Details

Daily high
$11.06
Daily low
$10.04
Price at open
$11.06
52 Week High
$24.50
52 Week Low
$8.89
Market cap
482.9M
Dividend yield
0.00%
Volume
291,905
Avg. volume
690,545
P/E ratio
--

Beta Bionics, Inc. - Common Stock News

Details

Daily high
$11.06
Daily low
$10.04
Price at open
$11.06
52 Week High
$24.50
52 Week Low
$8.89
Market cap
482.9M
Dividend yield
0.00%
Volume
291,905
Avg. volume
690,545
P/E ratio
--